Your browser doesn't support javascript.
What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy.
Goren, Andy; McCoy, John; Wambier, Carlos G; Vano-Galvan, Sergio; Shapiro, Jerry; Dhurat, Rachita; Washenik, Kenneth; Lotti, Torello.
  • Goren A; Applied Biology, Inc., Irvine, California, USA.
  • McCoy J; Applied Biology, Inc., Irvine, California, USA.
  • Wambier CG; Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Vano-Galvan S; Trichology Unit, Dermatology Department, Ramon y Cajal Hospital, IRYCIS, University of Alcala, Madrid, Spain.
  • Shapiro J; Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA.
  • Dhurat R; Department of Dermatology, LTM Medical College & Hospital Sion, Mumbai, India.
  • Washenik K; Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA.
  • Lotti T; Bosley Medical Group, Beverly Hills, California, USA.
Dermatol Ther ; 33(4): e13365, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-23335

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Receptors, Androgen / Coronavirus Infections / Alopecia Type of study: Observational study / Prognostic study Limits: Adult / Animals / Female / Humans / Male Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.13365

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Receptors, Androgen / Coronavirus Infections / Alopecia Type of study: Observational study / Prognostic study Limits: Adult / Animals / Female / Humans / Male Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.13365